Pfizer
Pharmaceuticals
World's largest research-based pharmaceuticals firm. Its products include Viagra, Benadryl and Sudafed. Bought Wyeth in 2009 for US$68 billion. In 2019 Pfizer and GSK merged their consumer healthcare divisions.

Overall

Owned USA
Rating D
About the Ratings
Pfizer Inc
USA

Company Assessment

(Last updated Oct 2024)
Pfizer Inc
Praise
CDP Climate Change score of A-
In 2023, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to reduce greenhouse gas emissions and mitigate climate change risk. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Climate Change score of A-.
Source: CDP (2023)
85.3/100 in Newsweek rankings
America's Most Responsible Companies 2022 by Newsweek and Statista recognises the Top 500 most responsible companies in the United States. Companies were evaluated in three areas: environmental (waste, energy use, etc.), social (leadership diversity, employees and philanthropy) and governance (transparency and economic performance). This company received a total score of 85.3/100, ranking 7th in the Health Care & Life Sciences sector, and 47th overall.
100% on Corporate Equality Index
This company is listed as having best practice on a report card on lesbian, gay, bisexual and transgender equality in corporate America.
CDP Water Security score of B
In 2023, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts to manage and govern freshwater resources. Responding companies are scored on six key metrics: transparency; governance & strategy; measuring & monitoring; risk assessment; targets & goals; and value chain engagement. This company received a CDP Water Security score of B.
Source: CDP (2023)
81% in AMR Benchmark
The 2021 Antimicrobial Resistance (AMR) Benchmark ranks 17 large pharmaceutical companies on their efforts keep medicines and vaccines available, despite the rise of drug resistance. This company was identified as a leader amongst large research-based companies, receiving a score of 81%.
Access to Medicine ranking
This company received the sixth highest score in the Access to Medicine Index 2022, a ranking of the world's 20 largest pharmaceutical companies on their efforts to increase access to medicine in developing countries. The ranking is based on their scores in each Technical Area, with Product Delivery weighted most highly, followed by R&D and Governance of Access.
JUST Capital ranking
JUST Capital polls Americans every year to identify the issues that matter most in defining just business behaviour. For their 2024 rankings the public identified 20 issues, which are organised under the headings Workers, Communities, Customers, Shareholders and Environment. JUST Capital then define metrics that map to those issues and track and analyse the largest, publicly traded U.S. companies. This analysis powers their rankings, in which this company ranked 218th of 937 companies, and 12th of 41 Pharmaceuticals & Biotech companies.
Criticism
1.7% in conflict minerals rankings
As You Sow's 2019 report, Mining the Disclosures, is a deep analysis of 215 companies' human rights performance in relation to sourcing conflict minerals from the Democratic Republic of the Congo (DRC). This company's score was 1.7% (Weak).
Animal Testing
This company appears on PETA's (People for the Ethical Treatment of Animals, USA) 'Companies That Do Test On Animals' list, signifying that they manufacture products that are tested on animals at some stage of development.
Source: PETA (2022)
Top spender on lobbying in USA
This company is on OpenSecrets.org's list of "Top Spenders on Lobbying", a list of the 20 organizations that have spent the most trying to influence US government policy. This company was in the top 20 list in 2022 and 2023, having spent $27,020,000 on lobbying in those 2 years.
5/18 in Net Zero scorecard
As You Sow's 2022 report, 'Road to Zero Emissions', assessed the progress of 55 of the largest U.S. corporations in reducing greenhouse gas (GHG) emissions in line with the Paris Agreement's objective of limiting global average temperature rise to 1.5 degrees Celsius above pre-industrial levels, which requires achieving "net zero" emissions by 2050. Companies are graded on: climate related disclosures; GHG reduction targets, and GHG reductions. This company received an Overall Net Zero grade of D.
Supply chain practices in China
The Green Supply Chain Corporate Information Transparency Index (CITI) evaluates consumer-facing companies that have a sizeable supply chain in China. The evaluation uses government supervision data and public information to assess the environmental management of their supply chains in China. This company received a score of 12.14/100 (retrieved 24 Nov 2023).
Source: IPE (2023)
6.5/20 in Social Benchmark
The 2024 Social Benchmark assesses the world's 2,000 most influential companies on their responsibility in meeting society's fundamental expectations towards three measurement areas: respecting human rights, providing decent work, and acting ethically. This company was assessed in 2022 and received a score of 6.5/20. The average score was an alarmingly low 4.6/20 and the highest score was 15.5/20.
$345m EpiPen settlement
In 2021 this company agreed to pay US$345 million to settle a class action lawsuit that claiming Pfizer and Mylan plotted to maintain EpiPen's monopoly by issuing large rebates to insurers and Medicaid plans that refused to cover competing medications. The class action was filed after the price of EpiPens rose from $100 to $600 in under 10 years.
Tax dodging
A 2018 report by Oxfam shows that four pharmaceutical corporations, including this one, systematically hide their profits in overseas tax havens. This activity could deprive developing countries of more than $100 million every year. These corporations deploy massive influencing operations to rig the rules in their favor and give their damaging behavior a veneer of legitimacy. Tax dodging, high prices, and influence peddling by drug companies exacerbate the yawning gap between rich and poor, between men and women, and between advanced economies and developing ones.
35/100 S&P Global ESG Score
This company received an S&P Global ESG Score of 35/100 in the Pharmaceuticals category of the S&P Global Corporate Sustainability Assessment, an annual evaluation of companies' sustainability practices (last updated 23 Sep 2022). The rankings are based on an analysis of corporate economic, environmental and social performance, assessing issues such as corporate governance, risk management, environmental reporting, climate strategy, human rights and labour practices.
$486m illegal marketing settlement
In 2016 this company agreed to pay US$486 million to settle litigation accusing it of causing big losses for shareholders by concealing safety risks associated with its Celebrex and Bextra pain-relieving drugs. The settlement ended more than 11 years of litigation.
CEO Pay Ratio of 437:1
In 2022 the median pay for a worker at this company was US$75,536. The CEO was paid 437 times this amount. Exorbitant CEO pay is a major contributor to rising inequality. CEOs are getting more because of their power to set pay, not because they are increasing productivity or possess specific, high-demand skills. The economy would suffer no harm if CEOs were paid less (or taxed more). In contrast, the CEO-to-typical-worker compensation ratio was 20-to-1 in 1965 and 58-to-1 in 1989.
$60m fraud settlement in USA
In 2019 several pharmaceutical companies finally settled a 2005 lawsuit which claimed the companies fudged wholesale drug prices to increase Medicaid reimbursements. In all, the state of Illinois received a combined $648 million over the course of that litigation. This company paid US$60 million in the 2019 settlement.
$39m Effexor antitrust settlement
In 2024 Pfizer agreed to a $39 million settlement with direct purchasers to resolve claims Pfizer unit Wyeth conspired with Teva Pharmaceuticals to delay generic versions of Effexor from reaching the marketplace. The settlement comes after 12 years of litigation and extensive mediation.
Information
Global Pollution & Chemical discharge
In 1992, Greenpeace listed a Pfizer plant as one of the ten worst polluters in the South East of England. The plant had breached its discharge consent four times since the beginning of 1991 and also discharged ten chemicals for which it did not have a permit, including organochlorines. Pfizer was the target of a Greenpeace campaign in 1988 for dumping industrial waste in Eire, and a US group listed Pfizer as one of the top fifteen corporate contributors to global pollution, based on 1987 figures. (Noted here as 'additional information only' due to age of report).'
Pollution in China
A 2015 report by Sum Of Us reveals that the largest pharmaceutical corporations are complicit in fuelling one of the most serious public health crises facing society today. Pharmaceutical companies, including this one, are sourcing active pharmaceutical ingredients (APIs) from companies in China which are responsible for massive environmental pollution from its antibiotic factories. Pfizer is among the well-known brand names which has sourced antibiotics for human and animal use from NCPC, a company that stands accused of discharging pharmaceutical effluent into the environment and numerous other serious manufacturing deficiencies.
Palm oil scorecard - WWF
The 2024 WWF Palm Oil Buyers Scorecard evaluates the progress and performance of 285 major retailers and manufacturer companies, focusing on actions companies have taken to ensure their own palm oil supply chain is sustainable and free of deforestation, natural ecosystem conversion, and human rights abuse. This company failed to respond to WWF's requests for information.
Fined US$2.3b for illegal marketing
In 2009 Pfizer copped the largest US criminal fine ever (US$2.3 billion), in the settlement of allegations that it had illegally marketed its painkiller Bextra and other drugs. Pfizer also faces lawsuits over other drugs, namely Reglan, Zoloft and Effexor. [Listed under Information due to age of court finding]
Corporate Criminals Alumni
This company appears on Global Exchange's list of "Most Wanted" Corporate Human Rights Violators (Alums) for killer price-gouging. [Listed under Information due to age of report]
Multinational Monitor's '10 Worst Corporations'
Named one of Multinational Monitor's '10 Worst Corporations' in 2006. [Listed under Information due to age of report]
Fined for illegal bribery
In August 2012 Pfizer agreed to pay a US$60 million court settlement after allegedly bribing foreign officials in Europe and Asia to speed up drug approvals, and give preference to Pfizer drugs in their countries' public health programs, which in turn generated billions of dollars for the world's largest drug company. [Listed under Information due to age of court finding]
Fines for misconduct
This company is listed on the Federal Contractor Misconduct Database as having 11 instances of misconduct since 1995 amounting to US$3.4 billion in penalties. Instances include illegal marketing, false claims, and whistleblower retaliation.
Excessive CEO pay
As You Sow's 2019 report, 'The 100 Most Overpaid CEOs', reveals the 100 most overpaid CEOs from USA's 500 largest public companies (as determined by the S&P 500 list). This company's CEO, Ian Read came in at number 44 on the list, having been paid US$27,913,775 in 2018. According to the report, "Most CEOs have come to be grossly overpaid, and that overpayment is harmful to the companies, the shareholders, the customers, the other employees, the economy, and society as a whole."
Climate action commitments
As listed on the We Mean Business website, this company has committed to the following climate action initiatives: adopt a science-based emissions reduction target.
Good Egg Award 2012 (UK)
Compassion in World Farming is a UK-based organisation which works with the European food industry to encourage and reward commitment, transparency, performance and innovation in the field of animal welfare. This company's UK subsidiary won their Good Egg Award in 2012.
UN Global Compact participant
The United Nations Global Compact asks companies to embrace, support and enact, within their sphere of influence, a set of 10 values in the areas of human rights, labour standards, the environment, and anti-corruption. However it's non-binding nature has been widely criticised, and many signatory corporations continue to violate the Compact's values.
AMR Industry Alliance member
This company is a member of the AMR Industry Alliance, a coalition of biotech, diagnostics, generics and research-based pharmaceutical companies set up to provide sustainable solutions to curb antimicrobial resistance (AMR). AMR is an increasingly significant threat to global public health which puts at risk the effective prevention and treatment of a wide range of infections.
CDP Forests score of C-
In 2023, the Carbon Disclosure Project (CDP) asked companies to provide data about their efforts towards removing commodity-driven deforestation and forest degradation from its direct operations and supply chains. Responding companies are scored across four key areas: disclosure; awareness; management; and leadership. This company received a CDP Forests score of C-.
Source: CDP (2023)
Modern Slavery statement
California, the UK and Australia have all enacted legislation requiring companies operating within their borders to disclose their efforts to eradicate modern slavery from their operations and supply chains. Follow the link to see this company's disclosure statement.
OpenSecrets.org profile
OpenSecrets.org tracks the influence of money on U.S. politics, and how that money affects policy and citizens' lives. Follow link to see this company's record of political donations, lobbying, outside spending and more.
29.9% in Nature Benchmark
The Nature Benchmark ranks 816 companies across 20 industries on their efforts to protect our environment and its biodiversity. Companies were assessed in three phases between 2022 and 2024 using three measurement areas: governance and strategy; social inclusion and community impact; and ecosystems and biodiversity. This company was assessed in 2022 and is ranked #79/816, with a total score of 29.9/100.
Corporate Rap Sheet
The Corporate Research Project's Corporate Rap Sheets are dossiers summarising the most significant crimes, violations and other questionable activities of the world's largest and most controversial companies. Follow link to see this company's Corporate Rap Sheet.
> About the Icons

Company Details

Type:
Public company
Revenue:
53.6 billion USD (2018)
Employees:
92,400 (2018)
Subsidiaries:
Wyeth Corporation
Pharmaceuticals, health care and animal health care products manufacturer
The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health. Bought by Pfizer in 2009 for US$68 billion.
Haleon plc (23% owned)
Healthcare
Established in July 2022 as a corporate spin-off from GSK. It is the largest consumer healthcare business in the world.
Haleon Australia Pty Ltd
Consumer healthcare
Formerly GlaxoSmithKline Consumer Healthcare Australia Pty Ltd. In 2019 GSK and Pfizer merged their consumer health businesses, creating a joint venture called GSK Consumer Healthcare, which was spun-off as a new entity named Haleon in 2022.

Contact Details

Address:
New York, New York, USA
Website:
www.pfizer.com

Products / Brands

Haleon Australia (23% owned)
Advil Pain Relief Tablets
Benefiber Laxatives
Biotene Mouthwash
Biotene Toothpaste
Caltrate Vitamins
Centrum Vitamins
De-Gas Digestive Care
Dimetapp Cold & Flu
Eno Digestive Care
Lamisil Foot Care
Macleans Toothbrush
Macleans Toothpaste
Macleans Mouthwash
Nicabate Quit Smoking
Otrivin Cold & Flu
Panadol Pain Relief Tablets
Panadol Cold & Flu
Panafen Pain Relief Tablets
Polident Toothpaste
Pronamel Toothpaste
Robitussin Cold & Flu
Sensodyne Mouthwash
Sensodyne Dental Floss
Sensodyne Toothpaste
Voltaren Topical Pain Relief
Zovirax Lip Care